Newron Spa (NWRN.SW) Market Summary
- Price movement: The stock closed unchanged at 0 % during the 24‑hour period ending 03:06 AM Central Europe on Saturday 24 th.
- Current price: CHF 8.64 on major exchanges.
- Shares outstanding: 21.2 million.
- Market capitalisation: CHF 185.3 million.
- Trading volume: CHF 388.9 k exchanged in the last 24 hours.
- Month‑end change: Down 23.15 % since the end of the previous month.
- 200‑day simple moving average: CHF 14.45.
- 52‑week range: Highest CHF 31.85 (01 Dec 2026); lowest CHF 5.72 (10 Aug 2026).
Performance of Related Stocks (24‑Hour View)
| Company | Ticker | 24‑Hour Change | Current Price | Market Capitalisation | P/E Ratio |
|---|---|---|---|---|---|
| Expertai Spa | EXAI.MI | +0.75 % | EUR 1.58 | EUR 197.1 million | – |
| Fnm Spa | FNM.MI | +0.37 % | EUR 0.40 | EUR 174 million | 2.69 |
| Terra Innovatum Global | NKLR | –0.45 % | USD 2.02 | USD 245.3 million | 0.56 |
| Racing Force Spa | RFG.MI | +1.19 % | EUR 5.04 | EUR 140.4 million | 19.67 |
| Societa Sportiva Lazio Spa | SSL.MI | –0.89 % | EUR 1.68 | EUR 123.3 million | – |
Company Overview
Newron Pharmaceuticals SpA is an Italian biopharmaceutical research and development company headquartered in Bresso, Milan. The firm focuses on developing therapies for central nervous system conditions, including Parkinson’s disease, neuropathic low back pain, and other cognitive disorders. The company is listed on the SIX Swiss Exchange and completed its initial public offering on 12 December 2006. Further information is available on the company website: www.newron.com .